Citadel Advisors
TPST icon

Citadel Advisors’s Tempest Therapeutics TPST Stock Holding History

Citadel Advisors’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22K Buy
+19,820
New +$32.7K ﹤0.01% 13385
2024
Q3 		– Sell
-7,095
Closed -$145K – 15268
2024
Q2 		$202K Buy
+7,095
New +$307K ﹤0.01% 9920
2024
Q1 		– Hold
0
– – – 14462
2023
Q4 		– Sell
-3,452
Closed -$163K – 15270
2023
Q3 		$14K Buy
+3,452
New +$33.1K ﹤0.01% 12897
2021
Q2 		– Sell
-2,054
Closed -$480K – 14447
2021
Q1 		$480K Sell
2,054
-2,135
-51% -$863K ﹤0.01% 9763
2020
Q4 		$1.75M Buy
4,189
+119
+3% +$41.1K ﹤0.01% 5637
2020
Q3 		$1.29M Buy
4,070
+810
+25% +$275K ﹤0.01% 5560
2020
Q2 		$1.12M Buy
3,260
+1,339
+70% +$534K ﹤0.01% 5627
2020
Q1 		$1.98M Buy
+1,921
New +$2.8M ﹤0.01% 4163
2018
Q2 		– Sell
-14
Closed -$33K – 9295
2018
Q1 		$33K Buy
+14
New +$42K ﹤0.01% 8031
2017
Q4 		– Sell
-20
Closed -$83K – 8444
2017
Q3 		$83K Buy
20
+16
+400% +$68.4K ﹤0.01% 7086
2017
Q2 		$17K Hold
4
– – ﹤0.01% 7319
2017
Q1 		$22K Hold
4
– – ﹤0.01% 7230
2016
Q4 		$16K Buy
+4
New +$49.8K ﹤0.01% 7125
2016
Q3 		– Sell
-8
Closed -$122K – 7778
2016
Q2 		$122K Buy
+8
New +$183K ﹤0.01% 6108
2015
Q4 		– Sell
-17
Closed -$413K – 9204
2015
Q3 		$413K Sell
17
-89
-84% -$5.99M ﹤0.01% 5069
2015
Q2 		$9.01M Buy
106
+8
+8% +$733K 0.01% 1543
2015
Q1 		$9.95M Buy
+98
New +$13.1M 0.01% 1456

Other funds holding TPST

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Citadel Advisors's TPST Position: Q2 2026 in Review

Citadel Advisors opened a new position in Tempest Therapeutics (TPST) in Q2 2026: 19,820 shares worth $22K. The stake represents ﹤0.01% of the portfolio and ranks #13385 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in TPST as recently as Q2 2024.

Citadel Advisors first reported a position in TPST in Q1 2015 and has held it in 17 quarters since. The position peaked at $9.95M in Q1 2015. 21 funds tracked by Wall St. Rank hold TPST as of Q2 2026.

  • Citadel Advisors held 19,820 shares of Tempest Therapeutics worth $22K as of Q2 2026.
  • Tempest Therapeutics was a new Citadel Advisors position in Q2 2026.
  • Tempest Therapeutics made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13385 holding.
  • Citadel Advisors first reported a position in Tempest Therapeutics in Q1 2015 and has held it in 17 quarters since.
  • Citadel Advisors's Tempest Therapeutics position peaked at $9.95M in Q1 2015.
  • 21 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.